Key Drivers
- Gross Margin
- Heavy Liabilities
- Cash Deterioration
AIAI Summary
ARX is transitioning from a simple specialty-insurance grower into a partner-led underwriting platform, but the key investment test is whether recent expansions with Incline, Hippo, and Lloyd's can convert into sustained cash earnings and not just faster premium growth, given the still-weak margins, negative ROE, and volatile cash flow.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Gross Margin
- •Heavy Liabilities
- •Cash Deterioration
ARX shows solid gross margins and a strong cash/investment base, but heavy liabilities, negative returns, and inconsistent cash flow keep its profitability and valuation case fragile.
Price Behavior
Key Price Behavior Insights:
- •Sharp rebound
- •Base forming
- •Overhead resistance
ARX remains in a short-term downtrend over the last month, but a sharp two-day rebound from $11.72 to $13.77 suggests a possible base is forming as price tests nearby resistance.
Sharp two-day rebound from $11.72 on 2026-06-30 to $13.77 on 2026-07-02
Sentiment & News
Key News Insights:
- •Partnership growth
- •Analyst upside
- •Insider sales
Accelerant/ARX headlines were boosted by major partnership expansion and analyst upside, but insider selling kept sentiment mixed.
The news is modestly positive for long-term growth, but insider selling could limit near-term upside and keep investors cautious
Similar Companies in Financial Services
Other companies in the same sector with AI ratings